Product
NBL-028
1 clinical trial
1 indication
Indication
Advanced Solid TumorClinical trial
A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of NBL-028 in Patients With Advanced Solid TumorsStatus: Recruiting, Estimated PCD: 2027-01-01